Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Mucolytic Age: Adult |
Dose: Oral – 300 mg Frequency: twice daily Duration: maximum 10 days |
|
Condition: Severe Hepatic Failure |
Dose: Oral – Not recommended Note: Use of erdosteine is not recommended in these patients as there are no data. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Creatinine clearance less than 25 mL/min |
Dose: Not recommended Note: Use is not recommended as there are no data for these patients. |
Administration
- Swallow capsule whole with water
- Take regularly as prescribed
Side Effect
- Epigastralgia
- nausea
- vomiting
- loose stools
- spasmodic colitis
- headache
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Drug Hypersensitivity
|
Risk of allergic reaction
|
|
Active Peptic Ulcer
|
Risk of gastrointestinal bleeding
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep in a dry place away from light and heat. Keep out of reach of children
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.